000			04234nam a22003735i 4500
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
988			_aSpringer_Medicine_2018
999			_c343878 _d343878 _x1
001			343878
003			ES-MaUEC
005			20230102120150.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			180927s2018 gw | s |||| 0|eng d
020			_a9783319926575
024	7		_a10.1007/978-3-319-92657-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aRC280.B8 _b2018 EB
245	1	0	_aAtypical Breast Proliferative Lesions and Benign Breast Disease _cedited by Farin Amersi, Kristine Calhoun.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XI, 197 páginas) _b28 ilustraciones, 24 ilustraciones a color
490			_aMedicine (Springer-11650)
505	0		_aThe Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors? -- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor? -- Ductal Carcinoma In Situ: Risk Factor or Cancer -- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision -- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated? -- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy -- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS -- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions -- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions -- The Role of Chemoprevention in the Prevention of Breast Cancer -- Prophylactic Mastectomy in Patients with Atypical Breast Lesions -- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS) -- Surgical Treatment of Ductal Carcinoma in Situ. .
520			_aThe days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. The goal of this book is to provide a concise but comprehensive review of atypical breast proliferative lesions and their management complexities. New data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions are discussed in full detail. Assessment tools for risk prediction of breast cancer are also highlighted as chapters run the gamut of current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Atypical Breast Proliferative Lesions and Benign Breast Disease will undoubtedly become a valuable resource for nurse practitioners, physician assistants, breast and surgical oncology fellows, genetic counselors, geneticists, as well as other clinicians and surgeons who are referred and manage these complex breast patients. All chapters in this text are written by experts in the field who have research and clinical interest in each of these disease entities, and include the most up-to-date research and clinical information to enhance our understanding and treatment of patients.
650		7	_2embne _9182522 _aMamas _xCáncer
700	1		_aAmersi, Farin. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aCalhoun, Kristine. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783319926568
776	0	8	_iPrinted edition: _z9783319926582
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-92657-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _a_alco _a_vill _b02/2019 _cm _dz _feng _ggw _h0